We are hiring three new team members!

We at the Flemingsberg Science Foundation are looking for three new team members to collaborate closely in driving the project “Cluster Engine Life Science Flemingsberg.”

About Us

The mission of the Flemingsberg Science Foundation is to increase knowledge-driven activities in Flemingsberg. We are on the path to becoming one of Sweden’s most important locations for education, research, and creativity. Already today, Campus Flemingsberg is one of the leading hubs for life science in Sweden. The foundation plays an active role in further developing this hub and will launch the project “Cluster Engine Life Science Flemingsberg” at the beginning of 2025. The project’s goal is to foster new collaborations and networks, create attractive meeting places and development environments for SMEs (small and medium-sized enterprises), attract more companies to the cluster, and enable more SMEs to collaborate with the unique research infrastructures available at Campus Flemingsberg.

  • Location: Flemingsberg, Huddinge
  • Position type: Full-time
  • Application deadline: January 7, 2025

This is a unique opportunity to work in a dynamic and growing environment where you can influence and contribute to the development of the life science sector in the Stockholm region. In Flemingsberg, you will become part of a network of dedicated and knowledgeable colleagues and partners.

Application

Send your application, including a CV and cover letter, to johnny.hogberg@flemingsbergscience.se by January 7, 2025. Please indicate which position you are applying for in the subject line.

See the role descriptions below:

Cluster Manager
Community Manager
Communicator/Marketer

Building a heart: Realheart aims to create new opportunities for patients with heart failure

A mechanical heart, as close to a human heart as it gets. Realheart is the company developing a total artificial heart for patients with advanced heart failure, a condition where treatment options are often limited. When we sit down with CEO Ina Laura Perkins, she tells the story of an innovation that has taken its time, about the strong drive to reach all the way to patients, and about steps that are bringing the company closer to clinical reality.

Go to Top